An in vivo evaluation of the effect of repeated administration and clearance of targeted contrast agents on molecular imaging signal enhancement

Theranostics

Volumn 3, Issue 2, 2013, Pages 93-98

  Streeter, Jason E ^a   Dayton, Paul A ^a  

^a Biomedical Research Imaging Center   (United States)

Author keywords

Contrast Agents; CRGD; Microbubble; Molecular Imaging; Targeted; Ultrasound

Indexed keywords

CONTRAST MEDIUM; CYCLIC ARGINYLALANYLASPARTYL DEXTRO TYROSYLCYSTEINE; CYCLOPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B SCAN; CLINICAL EVALUATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOSE RESPONSE; DRUG BINDING SITE; DRUG CLEARANCE; DRUG TARGETING; FIBROSARCOMA; IMAGE QUALITY; IN VIVO STUDY; MICROBUBBLE; MOLECULAR IMAGING; NONHUMAN; PILOT STUDY; RAT; REPEATED DRUG DOSE; THREE DIMENSIONAL IMAGING; ANIMAL; CONTRAST AGENTS; CRGD.; DISEASE MODEL; ECHOGRAPHY; FISCHER 344 RAT; METHODOLOGY; TARGETED; ULTRASOUND;

CONTRAST AGENTS; CRGD.; MICROBUBBLE; MOLECULAR IMAGING; TARGETED; ULTRASOUND;

ANIMALS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; FIBROSARCOMA; IMAGING, THREE-DIMENSIONAL; MOLECULAR IMAGING; RATS; RATS, INBRED F344; ULTRASONOGRAPHY;

MLCS; MLOWN;

EID: 84880945320     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.5341     Document Type: Article

References (26)

1. Gessner RC, Dayton PA. Advances in molecular imaging with ultrasound. Mol Imaging. 2010 Jun;9(3):117-27.
2. Kiessling F, Fokong S, Koczera P, Lederle W, Lammers T. Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics. J Nucl Med. 2012 Mar;53(3):345-8.
3. Weller GER, Villanueva FS, Tom EM, Wagner WR. Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi- targeting to ICAM-1 and sialyl Lewisx. Biotechnol Bioeng. 2005 Dec;92(6):780-8.
4. Dayton PA, Ferrara KW. Targeted imaging using ultrasound. J Magn Reson Imaging. 2002 Oct;16(4):362-77.
5. Leong-Poi H, Christiansen JP, Klibanov AL, Kaul S, Lindner JR. Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins. Circulation. 2003 Jan;107(3):455-60.
6. Streeter JE, Herrera-Loeza SG, Neel NF, Yeh JJ, Dayton PA. A Comparative Evaluation of Ultrasound Molecular imaging, Perfusion Imaging, and Volume Measurements in Evaluating Response to Therapy in Patient- Derived Xenografts. Technol Cancer Res Treat. 2012; In Press.
7. Sorace AG, Saini R, Mahoney M, Hoyt K. Molecular ultrasound imaging using a targeted contrast agent for assessing early tumor response to antiangiogenic therapy. J Ultrasound Med. 2012 Oct;31(10):1543-50.
8. Sirsi SR, Flexman ML, Vlachos F, Huang J, Hernandez SL, Kim HK, Johung TB, Gander JW, Reichstein AR, Lampl BS, Wang A, Hielscher AH, Kandel JJ, Yamashiro DJ, Borden MA. Contrast ultrasound imaging for identification of early responder tumor models to anti-angiogenic therapy. Ultrasound Med Biol. 2012 Jun;38(6):1019-29.
9. Gessner RC, Streeter JE, Kothadia R, Feingold S, Dayton PA. An In Vivo Validation of the Application of Acoustic Radiation Force to Enhance the Diagnostic Utility of Molecular Imaging Using 3-D Ultrasound. Ultrasound Med Biol. 2012 Apr;38(4):651-60.
10. Borden MA, Streeter JE, Sirsi SR, Dayton PA. An acoustically targeted, immune-stealth system for in vivo ultrasound assessment of angiogenesis. Manuscript in preparation.
11. Frinking PJA, Tardy I, Théraulaz M, Arditi M, Powers J, Pochon S, Tranquart F. Effects of Acoustic Radiation Force on the Binding Efficiency of BR55, a VEGFR2-Specific Ultrasound Contrast Agent. Ultrasound Med Biol. 2012 Aug;38(8):1460-9.
12. Willmann JK, Lutz AM, Paulmurugan R, Patel MR, Chu P, Rosenberg J, Gambhir SS. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. Radiology. 2008 Sep;248(3):936-44.
13. Streeter JE, Gessner RC, Miles I, Dayton PA. Improving sensitivity in ultrasound molecular imaging by tailoring contrast agent size distribution: in vivo studies. Mol Imaging. 2010 Apr;9(2):87-95.
14. Ruoslahti E. Integrins as signaling molecules and targets for tumor therapy. Kidney Int. 1997 May;51(5):1413-7.
15. Haubner R, Wester H-J. Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies. Curr Pharm Des. 2004;10(13):1439-55.
16. Dayton PA, Pearson D, Clark J, Simon S, Schumann PA, Zutshi R, Matsunaga TO, Ferrara KW. Ultrasonic analysis of peptide- and antibody- targeted microbubble contrast agents for molecular imaging of alphavbeta3-expressing cells. Mol Imaging. 2004 Apr;3(2):125-34.
17. Sirsi S, Feshitan JA, Kwan J, Homma S, Borden MA. Effect of microbubble size on fundamental mode high frequency ultrasound imaging in mice. Ultrasound Med Biol. 2010 Jun;36(6):935-48.
18. Feshitan JA, Chen CC, Kwan JJ, Borden MA. Microbubble size isolation by differential centrifugation. J Colloid Interface Sci. 2009 Jan 15;329(2):316-24.
19. Schroeder T, Yuan H, Viglianti BL, Peltz C, Asopa S, Vujaskovic Z, Dewhirst MW. Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat. Cancer Res. 2005 Jun;65(12):5163-71.
20. Streeter JE, Gessner RC, Tsuruta J, Feingold S, Dayton PA. Assessment of Molecular Imaging of Angiogenesis with Three-Dimensional Ultrasonography. Mol Imaging. 2011 Dec;10(6):460-68.
21. Stieger SM, Dayton PA, Borden MA, Caskey CF, Griffey SM, Wisner ER, Ferrara KW. Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents. Contrast Media Mol Imaging. Jan-Feb 2008;3(1):9-18.
22. Feingold S, Gessner RC, Guracar IM, Dayton PA. Quantitative volumetric perfusion mapping of the microvasculature using contrast ultrasound. Invest Radiol. 2010 Oct;45(10):669-74.
23. Johnson KA, Cianciolo R, Gessner RC, Dayton PA. A pilot study to assess markers of renal damage in the rodent kidney after exposure to 7 MHz ultrasound pulse sequences designed to cause microbubble translation and disruption. Ultrasound Med Biol. 2012 Jan;38(1):168-72.
24. Ellegala DB, Leong-Poi H, Carpenter JE, Klibanov AL, Kaul S, Shaffrey ME, Sklenar J, Lindner JR. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. Circulation. 2003 Jul;108(3):336-41.
25. Warram JM, Sorace AG, Saini R, Umphrey HR, Zinn KR, Hoyt K. A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature. J Ultrasound Med. 2011 Jul;30(7):921-31.
26. Tardy I, Pochon S, Theraulaz M, Emmel P, Passantino L, Tranquart F, Schneider M. Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55. Invest Radiol. 2010 Oct;45(10):573